ARTIVION, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ARTIVION, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $1.38M, a 394.60% increase year-over-year.
- ARTIVION, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $178.00K, a 94.47% decline year-over-year.
- ARTIVION, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $3.46M, a 681.26% increase year-over-year.
- ARTIVION, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $3.87M, a 472.49% increase year-over-year.
- ARTIVION, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $10.83M, a 172.98% increase from fiscal 2024.
- ARTIVION, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $3.97M, a 58.55% increase from fiscal 2023.
- ARTIVION, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $2.50M, a 39.85% increase from fiscal 2022.
- ARTIVION, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $1.79M, a 16.64% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $1.38M 10-Q · filed 2026-08-07 | $8.88M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $178.00K 10-Q · filed 2026-05-08 | $7.79M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $10.83M 10-K · filed 2026-02-18 |
| 2025-09-30 | $3.87M 10-Q · filed 2025-11-07 | $7.81M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $278.00K 10-Q · filed 2026-08-07 | $4.62M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $3.22M 10-Q · filed 2026-05-08 | $4.40M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $443.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $3.97M 10-K · filed 2026-02-18 |
| 2024-09-30 | $676.00K 10-Q · filed 2025-11-07 | $4.02M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-30 | $59.00K 10-Q · filed 2025-08-08 | $3.34M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-31 | $2.79M 10-Q · filed 2025-05-06 | $3.29M derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-31 | $496.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $2.50M 10-K · filed 2026-02-18 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $2.03M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $2.12M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $2.01M 10-Q · filed 2024-05-07 | $2.12M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.79M 10-K · filed 2025-02-28 |
| 2022-09-30 | $85.00K 10-Q · filed 2023-11-03 | $1.99M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $2.10M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $1.68M 10-Q · filed 2023-05-05 | $3.56M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $224.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $2.15M 10-K · filed 2024-02-23 |
| 2021-09-30 | $191.00K 10-Q · filed 2022-11-04 | $2.27M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $1.46M 10-Q · filed 2022-08-05 | $2.12M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $271.00K 10-Q · filed 2022-05-06 | $766.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $353.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $871.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | $31.00K 10-Q · filed 2021-11-05 | $756.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $111.00K 10-Q · filed 2021-07-30 | $778.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $376.00K 10-Q · filed 2021-04-30 | $2.22M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $3.29M 10-K · filed 2022-02-22 |
| 2019-09-30 | $53.00K 10-Q · filed 2020-11-05 | $3.12M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $1.55M 10-Q · filed 2020-07-31 | $5.16M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $1.45M 10-Q · filed 2020-05-01 | $3.95M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $2.52M 10-K · filed 2021-02-23 |
| 2018-09-30 | $2.10M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $337.00K 10-Q · filed 2019-07-31 | |
| 2018-03-31 | $18.00K 10-Q · filed 2019-05-02 | |
| 2017-12-31 | $1.90M 10-K · filed 2020-02-19 | |
| 2016-12-31 | $1.37M 10-K · filed 2019-02-26 | |
| 2015-12-31 | $837.00K 10-K · filed 2018-03-09 | |
| 2014-12-31 | $1.96M 10-K · filed 2017-02-16 | |
| 2013-12-31 | $1.73M 10-K · filed 2016-02-16 | |
| 2012-12-31 | $37.00K 10-K · filed 2015-02-17 | |
| 2011-12-31 | $408.00K 10-K · filed 2014-02-21 | |
| 2010-12-31 | $18.00K 10-K · filed 2013-02-15 | |
| 2009-12-31 | $349.00K 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |